Ricoh IM C3010 Wins 2025 Pick Award from Keypoint Intelligence
TOKYO, May 26, 2025 /PRNewswire/ -- The RICOH IM C3010 A3 colour multifunction printer has been named a "Highly Recommended" device and selected for a 2025 BLI Pick Award by Keypoint Intelligence, a leading independent evaluator of document imaging solutions.
Engineered with enterprise-grade capabilities, the IM C3010 is built to support modern work environments by offering a powerful, secure and flexible solution that streamlines workflows and enhances productivity. This BLI award acknowledges the device's exceptional performance, intuitive usability, and advanced document handling.
"Recognition like this reinforces how we're helping customers respond to the growing need for smarter, more secure ways of working," said Kei Uesugi, Managing Director of Ricoh Asia Pacific. "The IM C3010 combines strong performance with everyday usability, giving businesses the tools to manage documents more efficiently and adapt with confidence."
Key Features of the IM C3010
Smart Operation Panel: 10.1-inch touchscreen with customisable workflows and one-touch task presets to simplify day-to-day use.
Fast, Reliable Performance: Quick first-print-out times and consistent job handling for both short and long runs in busy office environments.
Advanced Scanning & OCR: High-speed duplex scanning with accurate text recognition and compact file output for efficient digitisation.
Robust Security: Integrated features such as secure print, user authentication and data encryption to help protect sensitive information.
Mobile & Cloud Ready: Built-in support for AirPrint, Mopria, and Ricoh Smart Device Connector, plus cloud services via Ricoh Smart Integration.
Powering Smart, Secure Workflows
The IM C3010 excels in high-demand office environments, combining exceptional speed, advanced scanning capabilities and robust security features. Its intuitive Smart Operation Panel, accurate OCR performance, and seamless mobile and cloud integration make it ideally suited for organisations seeking to digitise documents efficiently and manage workflows securely. Designed to adapt to changing workplace needs, the IM C3010 supports scalable, future-ready document management.
-Ends-
About the BLI Pick Awards and Keypoint Intelligence:
The BLI Pick Awards, presented by Keypoint Intelligence, are widely recognised as a mark of excellence in the print and imaging industry. These awards are based on comprehensive hands-on testing and assessment of key performance areas, including reliability, usability, image quality, productivity, and overall value. Only the top-performing devices in each category earn a coveted "Pick".
Keypoint Intelligence has been a trusted authority in digital imaging for over 60 years, offering independent lab testing, market research and strategic insights to manufacturers, partners and end users. Its evaluations help businesses identify solutions that deliver measurable performance in real-world environments — making a BLI Pick Award a clear signal of product quality and competitive strength.
About Ricoh
Ricoh is a leading provider of integrated digital services and print and imaging solutions designed to support the digital transformation of workplaces, workspaces and optimise business performance.
Headquartered in Tokyo, Ricoh's global operation reaches customers in approximately 200 countries and regions, supported by cultivated knowledge, technologies, and organisational capabilities nurtured over its 85-year history. In the financial year ended March 2025, Ricoh Group had worldwide sales of 2,527 billion yen (approx. 16.8 billion USD).
It is Ricoh's mission and vision to empower individuals to find 'Fulfillment through Work' by understanding and transforming how people work so we can unleash their potential and creativity to realise a sustainable future.
For further information, please visit www.ricoh.com
###
© 2025 RICOH ASIA PACIFIC PTE LTD. All rights reserved. All referenced product names are the trademarks of their respective companies.
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/ricoh-im-c3010-wins-2025-pick-award-from-keypoint-intelligence-302462971.html
SOURCE Ricoh Asia Pacific Pte Ltd
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Compounding Pharmacy Market and Pharma Manufacturing Poised for Strong, Parallel Growth by 2030
HYDERABAD, India, Aug. 11, 2025 /PRNewswire/ -- Mordor Intelligence recently released comprehensive reports on compounding pharmacy market and pharma manufacturing industry, detailing robust growth trajectories for both sectors. Driven by increasing demand for personalized therapies and advanced production technologies, these markets are set to expand significantly through 2030, creating strategic opportunities for stakeholders across the healthcare value chain. Compounding Pharmacy Market Outlook The compounding pharmacy market, valued at approximately USD 15.1 billion in 2025, is forecast to reach nearly USD 20 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7%, says Mordor Intelligence. Growth stems from rising demand for customized medications, chronic pain management alternatives, and expanded bio-identical hormone therapies. Personalized formulations for pediatric and geriatric patients further bolster market uptake, ensuring precise dosing and improved adherence. "Our analysis indicates that the compounding sector is becoming a vital component of modern therapeutics," according to the Mordor Intelligence report on compounding pharmacies. "Continued API localization and advanced sterile workflows are key to meeting growing volumes while maintaining rigorous quality standards." For more details on the compounding pharmacy market report, visit: Key Drivers Behind Compounding Pharmacy Growth Personalized Medication Demand: Tailored pain-management mixes and hormone therapies address individual patient needs. Regulatory Frameworks: Guidelines permitting compounding during commercial drug shortages enhance market resilience. Technological Integration: Automated sterile systems and digital quality assurance streamline high-volume operations. Pharmaceutical Manufacturing Market Dynamics According to Mordor Intelligence, the pharmaceutical manufacturing market stands at roughly USD 506 billion in 2025 and is expected to ascend to approximately USD 811 billion by 2030, exhibiting a CAGR of 9.9%. Growth is anchored by reshoring incentives, continuous manufacturing adoption, and expansion of biosimilar capacity. Investment in AI-driven quality-control systems and modular plant designs accelerates time-to-market and supports diversified supply chains. "Advanced production technologies and regulatory support for continuous processes are transforming manufacturing economics," as per Mordor Intelligence's pharma manufacturing research report. "These trends enable manufacturers to balance scale with flexibility, essential for both blockbuster and niche therapies." For more details on the pharmaceutical manufacturing market report, visit: Emerging Trends in Pharmaceutical Manufacturing Continuous Processing Adoption: Cutting facility footprints and operating costs, supported by clear regulatory pathways. Biosimilar Surge: Patent expirations drive contract development and manufacturing organization (CDMO) engagement. Digital Integration: AI, IoT, and automation improve throughput, predictive maintenance, and batch-release timelines. Synergies and Market Implications Together, the rapid expansion of compounding pharmacies and the modernization of pharmaceutical manufacturing underscore a broader shift toward personalized, efficient, and resilient healthcare supply chains. Stakeholders—from CXOs and business analysts to healthcare research institutes—should monitor these intersecting markets for strategic partnerships, investment opportunities, and supply-chain optimizations. As these markets evolve, organizations equipped with actionable intelligence can capitalize on specialized formulations and advanced manufacturing capabilities. Mordor Intelligence's dual insights drive informed decision-making, empowering clients to navigate complexity and achieve sustainable growth in an increasingly competitive landscape. Explore more reports on the healthcare industry at Related Reports: Animal Drug Compounding Market: The market is projected to grow from USD 1.43 billion in 2025 to USD 2.04 billion by 2030 at a 7.4% CAGR. Growth is driven by personalized pet therapies, cannabinoid-based formulations, FDA-driven shortages, and AI-enabled compounding, while regulatory compliance and rising costs remain key Veterinary Drugs Market: The global market is projected to grow at a CAGR of 5.8%, driven by rising infectious diseases in pets and livestock, advancements in biologics, and increasing demand for animal-based products. The Lumpy Skin Disease (LSD) outbreak in Asia is accelerating vaccine R&D, with companies like Hester Biosciences developing vaccines to address this need. Such disease outbreaks and innovation efforts are expected to fuel market growth during the forecast OTC Drugs Market: The market is projected to grow from USD 195.96 billion in 2025 to USD 247.74 billion by 2030 at a 4.8% CAGR. Growth is driven by rising self-care trends, regulatory shifts enabling prescription-to-OTC switches, and demand for convenient formats like gummies and patches. Companies are adopting digital self-selection tools, track-and-trace technology, and omnichannel retail models to enhance trust and accessibility, especially in regions with high counterfeit risk. About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. For any inquiries, please contact:media@ 617-765-2493 Logo: View original content to download multimedia: SOURCE Mordor Intelligence Private Limited Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
8 minutes ago
- Yahoo
Lithium stocks soar after world's largest EV battery maker shutters mine in China
Lithium stocks soared early Monday after the world's largest EV battery maker closed its lithium mine in China, sending lithium prices soaring. The spike in lithium companies' stocks comes after Contemporary Amperex Technology (C7A0.F) announced early Monday morning that it was halting operations at one of its most important mines in China — also one of the world's largest — after its permit for the mine expired. The company said the Jianxiawo mine, the largest in China's Yichun lithium hub, will be shuttered for three months while it seeks to renew its license, according to Bloomberg. CATL is the largest EV battery manufacturer in the world, holding more than a third of the market. Shares of Albemarle (ALB) and Sociedad Química y Minera (SQM), the two largest lithium producers in the world, were up more than 11% and 9%, respectively, in early trading. Fellow major lithium miners and processors Lithium Americas (LAC) and Sigma Lithium (SGML) were up over 8% and 16%, respectively. The price of spot lithium was up nearly 4% on Monday; lithium prices have risen over 15% in the past month. Elon Musk's Tesla (TSLA) is one of CATL's biggest customers, according to a report from the Shanghai Metals Market. Tesla stock was up 2% early Monday morning. In January, the US Department of Defense added CATL to a list of companies it says are affiliated with the Chinese military. This would ban the Defense Department from signing procurement contracts with the company beginning in June 2026 CATL's move to shutter its mine will likely be seen as reflective of Beijing's increasing crackdown on "involution," which it sees as a phenomenon where increasing competitive prices for resources like lithium are self-defeating and end up slowing development instead of spurring it, according to the Financial Times. Lithium's centrality to the global market has exploded over the past few years due to the metal's key role in electric vehicles, storage capacity on power grids, and a variety of electronics, including phones and laptops. Demand for the metal could grow by as much as 40% by 2040, according to a forecast from the International Energy Agency. Lithium prices had fallen sharply over the past couple of years, hitting their lowest level since 2021 in June after dropping 20% from the start of the year, as mines around the world have continued to produce the rare-earth metal even as output has outpaced demand. Production in China alone has risen by 55% since 2023, according to data from commodities pricing agency Fastmarkets. "At this time, we see limited upside in the short term with a lack of pricing and market dynamics change, but also limited downside as we believe the market has bottomed out," UBS analysts wrote in a July research note. "This leaves investors in a 'no man's land', where trading and taking positions into equities is challenging." Jake Conley is a breaking news reporter covering US equities for Yahoo Finance. Follow him on X at @byjakeconley or email him at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 minutes ago
- Yahoo
FUJIFILM Announces Expanded Capabilities for REVORIA PRESS™ Series with New Workflow, Specialty Toners, and Finishing Solutions
HANOVER PARK, Ill., August 11, 2025--(BUSINESS WIRE)--FUJIFILM North America Corporation, Business Innovation Division, today announced three significant updates to its FUJIFILM REVORIA PRESS™ series designed to enhance productivity, expand creative possibilities, and streamline production for print service providers of all sizes. The new offerings include the availability of the Revoria XMF PressReady Lite workflow solution, new Silver & White specialty toners for select models, and the availability of the Plockmatic Booklet Maker on its EC2100 Series. "These new enhancements to our REVORIA PRESS series underscore our commitment to providing innovative and flexible solutions that help our customers thrive in a competitive market," said Yuji Oki, general manager, FUJIFILM North America Corporation, Business Innovation Division. "Whether it's a small shop needing an efficient workflow solution or a commercial printer looking to expand its specialty printing capabilities, these updates offer tangible benefits that drive business growth and customer satisfaction." Revoria XMF PressReady LiteA direct response to market need, the Revoria XMF PressReady Lite is a customized version of Fujifilm's original XMF PressReady workflow solution that is specifically designed to add value to smaller companies, especially those that only use one or two presses for production. The simplified, cost-effective workflow solution allows print providers to automate key tasks - including full PDF preflighting, file error detection and correction - in addition to creating automated workflows that intelligently group jobs by similar media or toner needs, minimizing changeovers and maximizing efficiency, ultimately saving time and reducing human error. As a software add-on, PressReady Lite can be installed on a Revoria Flow server configured for use with Fujifilm's Revoria Press SC285, EC2100, and PC1120 models. Silver & White Specialty TonersTo empower customers with the ability to produce more dynamic designs, Fujifilm is introducing new Silver & White specialty toners for its REVORIA PRESS EC2100S and SC285S models. Significantly broadening the creative potential and commercial appeal of digital print applications, these additions join the existing Pink, Clear, and Textured Clear options. The addition of Silver toner allows customers to produce stunning metallic effects that elevate branding for higher perceived value, making it ideal for high-end business cards, brochures, and promotional materials. White toner enables the production of vibrant, high-impact images on dark, transparent substrates, which is perfect for premium innovative marketing collateral. Together the addition of these two toners offers versatility without compromised quality, facilitates efficient workflows, allowing five-color printing in a single pass, and ultimately enables customers to differentiate in competitive markets. Plockmatic Booklet Maker Availability for EC2100 SeriesCompleting the comprehensive update, the Plockmatic Booklet Maker will now be available on the Revoria Press EC2100 series. This in-line finishing solution streamlines the production of high-quality booklets, brochures, and catalogs, reducing manual post-press processes and further increasing overall productivity. The Plockmatic Booklet Maker offers seamless integration, providing a complete end-to-end solution for a wide range of applications. Each of these solutions is now available in the North American market. For more information on Fujifilm's Business Innovation products, visit About Fujifilm FUJIFILM North America Corporation, a marketing subsidiary of FUJIFILM Holdings America Corporation, consists of six operating divisions. The Imaging Division provides consumer and commercial photographic products and services, including silver halide consumables; inkjet consumables; digital printing equipment, along with service and support; personalized photo products fulfillment; film; one-time-use cameras; and the popular INSTAX® line of instant cameras, smartphone printers, instant film, and accessories. The Electronic Imaging Division markets its GFX System and X Series lines of mirrorless digital cameras, lenses, and accessories to provide a variety of content creation solutions for both still and moving imagery. The Optical Devices Division provides optical lenses for the broadcast, cinematography, closed circuit television, videography, and industrial markets, and also markets binoculars and other optical imaging solutions. The Business Innovation Division offers a full lineup of digital print and toner technologies focused on enabling the digital transformation of businesses and print shops with its offerings of multifunction printers, digital inkjet presses, production toner printers, software, and more. The Industrial Products Division delivers new products derived from Fujifilm technologies including data storage tape products, including OEM and FUJIFILM Ultrium LTO cartridges, desalination solutions, microfilters and gas separation membranes. For more information, please visit go to to follow Fujifilm on X, or go to to Like Fujifilm on Facebook. FUJIFILM Corporation is a subsidiary of FUJIFILM Holdings Corporation. FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of "giving our world more smiles," we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen (29 billion USD at an exchange rate of 140 JPY/USD). For more information, please visit: For further details about our commitment to sustainability and Fujifilm's Sustainable Value Plan 2030, click here. FUJIFILM, REVORIA PRESS, and instax are trademarks of FUJIFILM Corporation and its affiliates. © 2025 FUJIFILM North America Corporation and its affiliates. All rights reserved. View source version on Contacts Media Contact:Daniel CarpenterFUJIFILM Holdings America Sign in to access your portfolio
